Ligand Pharmaceuticals reported $14.51M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Amgen USD 6.39B 169M Sep/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Baxter International USD 2.3B 41M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Enviri Corporation USD 173.28M 7.27M Mar/2026
Gilead Sciences USD 1.9B 57M Sep/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
Glaxosmithkline GBP 6.3B 143M Sep/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 163.95M 21.56M Sep/2026
Intrexon USD 287K 68K Dec/2022
Ionis Pharmaceuticals USD 28.58M 22.26M Sep/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 14.51M 4.24M Sep/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Merck USD 6.16B 43M Sep/2026
Pacira USD 3.83B 3.69B Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Veracyte USD 25.82M 3.16M Sep/2026